Abstract
Available data indicate that minocycline, an antibiotic of the tetracycline family, has cytoprotective properties due to a direct interaction with mitochondria. Yet, the data in the case of isolated mitochondria suggest discrepant or even detrimental effect(s) of the interaction. We have studied the cytoprotective activity displayed by minocycline in the case of the yeast Saccharomyces cerevisiae cells pretreated with H2O2. We demonstrated that the activity of minocycline required the presence of VDAC (voltage-dependent anion-selective channel) and provided distinct improvement of mitochondrial coupling. In the case of isolated mitochondria, we verified that minocycline exhibited uncoupler activity when applied in micromolar concentrations. However, when added in nanomolar concentrations, minocycline was able to improve the level of coupling for isolated mitochondria. The coupling improvement effect was observed in mitochondria containing VDAC but not in Δpor1 mitochondria (depleted of VDAC1, termed here VDAC) and in both types of mitoplasts. Thus, properly low concentrations of minocycline within the cell in the vicinity of VDAC-containing mitochondria enable the improvement of energy coupling of mitochondria that contributes to cytoprotective activity of minocycline.
Article PDF
Similar content being viewed by others
References
Abdel-Salam OM (2008) CNS Neurol Disord Drug Targets 7:321–342
Antonenko YN, Rokitskaya TI, Cooper AJ, Krasnikov BF (2010) J Bioenerg Biomembr 42:151–163
Antos N, Stobienia O, Budzińska M, Kmita H (2001) J Bioenerg Biomembr 33:119–126
Blachly-Dyson E, Song J, Wolfgang WJ, Colombini M, Forte M (1997) Mol Cell Biol 17:5727–5738
Boubekeur S, Camougrand N, Bunoust O, Rigoulet M, Guerin B (2001) Eur J Biochem 268:5057–5065
Chen X, Ma X, Jiang Y, Pi R, Liu Y, Ma L (2011) J Neuroimmunol 235:1–8
Cornet S, Spinnewyn B, Delaflotte S, Charnet C, Roubert V, Favre C, Hider H, Chabrier PE, Auguet M (2004) Eur J Pharmacol 505:111–119
Crichton PG, Affourtit C, Moore AL (2004) Biochem J 401:459–464
Cuenca-Lopez MD, Karachitos A, Massarotto L, Oliveira PJ, Aguirre N, Galindo MF, Kmita H, Jordan J (2011) Pharm Res. doi:10.1016/j.phrs.2011.08.007
Daum G, Gasser SM, Schatz G (1982) J Biol Chem 257:13075–13080
De Vries S, Marres CA (1987) Biochim Biophys Acta 895:205–239
Douce R, Bourguignon R, Neuberger M (1984) Meth Enzymol 148:403–415
Fagan SC, Waller JL, Nichols FT, Edwards DJ, Pettigrew LC, Clark WM, Hall CE, Switzer JA, Ergul A, Hess DC (2010) Stroke 41:2283–2287
Fernandez-Gomez FJ, Galindo MF, Gomez-Lazaro M, González-García C, Ceña V, Aguirre N, Jordán J (2005) Neuroscience 133:959–967
Fong JS, Rae-Grant A, Huang D (2008) Recent Pat CNS Drug Discov 3:153–165
Gałgańska H, Karachitos A, Baranek M, Budzińska M, Jordán J, Kmita H (2010) Eur J Pharmacol 643:42–47
Garcia-Martinez EM, Sanz-Blasco S, Karachitos A, Bandez MJ, Fernandez-Gomez FJ, Perez-Alvarez S, de Mera RM, Jordan MJ, Aguirre N, Galindo MF, Villalobos C, Navarro A, Kmita H, Jordán J (2010) Biochem Pharmacol 79:239–250
Gieseler A, Schultze AT, Kupsch K, Haroon MF, Wolf G, Siemen D, Kreutzmann P (2009) Biochem Pharmacol 77:888–896
Gupta YK, Chauhan A (2011) Indian J Med Res 133:15–26
Hashimoto K (2011) Ann Neurol 69:739
Hawryluk GW, Rowland J, Kwon BK, Fehlings MG (2008) Neurosurg Focus 25:E14
Jackson AC, Scott CA, Owen J, Weli SC, Rossiter JP (2007) J Virol 81:6248–6253
Jordan J, Fernandez-Gomez FJ, Ramos M, Ikuta I, Aguirre N, Galindo MF (2007) Curr Drug Deliv 4:225–231
Kim HS, Suh YH (2009) Behav Brain Res 196:168–179
Kmita H, Budzińska M (2000) Biochim Biophys Acta 1509:86–94
Kreutzmann P, Wolf G, Kupsch K (2010) Cell Mol Neurobiol 30:979–984
Kupsch K, Hertel S, Kreutzmann P, Wolf G, Wallesch CW, Siemen D, Schönfeld P (2009) FEBS J 276:1729–1738
Lee AC, Xu X, Blachly-Dyson E, Forte M, Colombini M (1998) J Membr Biol 161:173–181
Lu L, Li F, Wang X (2010) CNS Neurol Disord Drug Targets 9:232–240
Magherini F, Tani C, Gamberi T, Caselli A, Bianchi L, Bini L, Modesti A (2007) Proteomics 7:1434–1445
Mansson R, Morota S, Hansson MJ, Sonoda I, Yasuda Y, Shimazu M, Sugiura A, Yanagi S, Miura H, Uchino H, Elmér E (2010) Hepatology 51:347–348
Matsukawa N, Yasuhara T, Hara K, Xu L, Maki M, Yu G, Kaneko Y, Ojika K, Hess DC, Borlongan CV (2009) BMC Neurosci 10:126
Michejda J, Guo XJ, Lauquin GJ (1990) Biochem Biophys Res Commun 171:354–361
Nicholls DG, Ferguson SF (2001) Bioenergetics 3. Academic, London
Paribello C, Tao L, Folino A, Berry-Kravis E, Tranfaglia M, Ethell IM, Ethell DW (2010) BMC Neurol 10:91
Plane JM, Shen Y, Pleasure DE, Deng W (2010) Arch Neurol 67:1442–1448
Spencer C, Symons SA, Brunt RV (1971) Arch Mikrobiol 75:246–259
Vandekerckhove BN, Quirynen M, van Steenberghe D (1998) J Clin Periodontol 25:964–968
Wang KK, Larner SF, Robinson G, Hayes RL (2006) Curr Opin Neurol 19:514–519
Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu DC, Gullans S, Ferrante RJ, Przedborski S, Kristal BS, Friedlander RM (2002) Nature 417:74–78
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Karachitos, A., Jordan, J. & Kmita, H. Cytoprotective activity of minocycline includes improvement of mitochondrial coupling: the importance of minocycline concentration and the presence of VDAC. J Bioenerg Biomembr 44, 297–307 (2012). https://doi.org/10.1007/s10863-012-9441-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-012-9441-4